Yongjun Sun - Search Results

Year	Number of Results
2004	1
2008	1
2009	1
2010	1
2012	6
2013	7
2014	5
2015	4
2016	6
2017	11
2018	11
2019	21
2020	18
2021	18
2022	16
2023	6
2024	3

1

The differences between GluN2A and GluN2B signaling in the brain.

Sun Y, Xu Y, Cheng X, Chen X, Xie Y, Zhang L, Wang L, Hu J, Gao Z. Sun Y, et al. J Neurosci Res. 2018 Aug;96(8):1430-1443. doi: 10.1002/jnr.24251. Epub 2018 Apr 22. J Neurosci Res. 2018. PMID: 29682799 Review.

2

Progresses in GluN2A-containing NMDA Receptors and their Selective Regulators.

Niu M, Yang X, Li Y, Sun Y, Wang L, Ha J, Xie Y, Gao Z, Tian C, Wang L, Sun Y. Niu M, et al. Among authors: sun y. Cell Mol Neurobiol. 2023 Jan;43(1):139-153. doi: 10.1007/s10571-021-01185-1. Epub 2022 Jan 3. Cell Mol Neurobiol. 2023. PMID: 34978648 Review.

3

Synthetic methods of lipid-coated mesoporous silica nanoparticles as drug carriers.

Sun Y, Xu Y, Sun Y, Hu B, Wang L, Du Z, Gao Z. Sun Y, et al. Biointerphases. 2022 Mar 1;17(2):020801. doi: 10.1116/6.0001688. Biointerphases. 2022. PMID: 35232023 Review.

4

Lipid membranes supported by planar porous substrates.

Sun Y, Zang X, Sun Y, Wang L, Gao Z. Sun Y, et al. Chem Phys Lipids. 2020 May;228:104893. doi: 10.1016/j.chemphyslip.2020.104893. Epub 2020 Feb 22. Chem Phys Lipids. 2020. PMID: 32097619 Review.

5

Neuroprotective effect of resveratrol against glutamate-induced excitotoxicity.

Zhang LN, Hao L, Wang HY, Su HN, Sun YJ, Yang XY, Che B, Xue J, Gao ZB. Zhang LN, et al. Adv Clin Exp Med. 2015 Jan-Feb;24(1):161-5. doi: 10.17219/acem/38144. Adv Clin Exp Med. 2015. PMID: 25923101 Free article. Review.

6

Application of Advanced Oxidation Technology in Sludge Conditioning and Dewatering: A Critical Review.

Xia J, Ji J, Hu Z, Rao T, Liu A, Ma J, Sun Y. Xia J, et al. Among authors: sun y. Int J Environ Res Public Health. 2022 Jul 29;19(15):9287. doi: 10.3390/ijerph19159287. Int J Environ Res Public Health. 2022. PMID: 35954642 Free PMC article. Review.

7

Phased Treatment Strategies for Cerebral Ischemia Based on Glutamate Receptors.

Sun Y, Feng X, Ding Y, Li M, Yao J, Wang L, Gao Z. Sun Y, et al. Front Cell Neurosci. 2019 Apr 26;13:168. doi: 10.3389/fncel.2019.00168. eCollection 2019. Front Cell Neurosci. 2019. PMID: 31105534 Free PMC article. Review.

8

Nanotechnology applied to overcome tumor drug resistance.

Gao Z, Zhang L, Sun Y. Gao Z, et al. Among authors: sun y. J Control Release. 2012 Aug 20;162(1):45-55. doi: 10.1016/j.jconrel.2012.05.051. Epub 2012 Jun 12. J Control Release. 2012. PMID: 22698943 Review.

9

Treatment of Cerebral Ischemia Through NMDA Receptors: Metabotropic Signaling and Future Directions.

Li Y, Cheng X, Liu X, Wang L, Ha J, Gao Z, He X, Wu Z, Chen A, Jewell LL, Sun Y. Li Y, et al. Among authors: sun y. Front Pharmacol. 2022 Feb 21;13:831181. doi: 10.3389/fphar.2022.831181. eCollection 2022. Front Pharmacol. 2022. PMID: 35264964 Free PMC article. Review.

10

Therapeutic time windows of compounds against NMDA receptors signaling pathways for ischemic stroke.

Huo Y, Feng X, Niu M, Wang L, Xie Y, Wang L, Ha J, Cheng X, Gao Z, Sun Y. Huo Y, et al. Among authors: sun y. J Neurosci Res. 2021 Dec;99(12):3204-3221. doi: 10.1002/jnr.24937. Epub 2021 Oct 21. J Neurosci Res. 2021. PMID: 34676594 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

111 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

111 results

Results by year